The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

G Van Assche, A Dignass, W Reinisch… - Journal of Crohn's …, 2010 - academic.oup.com
Fistulating Crohn's disease (CD) comprises fistulae arising in the perianal area, together
with those communicating between the intestine and other organs or the abdominal wall …

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease

WJ Sandborn, BG Feagan, SB Hanauer, H Lochs… - Gastroenterology, 2002 - Elsevier
Advances in immunology, biotechnology, and phar-maceutical science have resulted in an
unprecedented number of medications with potential application to the treatment of Crohn's …

3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: part 2: surgical management and special situations

P Gionchetti, A Dignass, S Danese… - Journal of Crohn's …, 2017 - academic.oup.com
This paper is the second in a series of two publications relating to the European Crohn's and
Colitis Organisation [ECCO] evidence-based consensus on the diagnosis and management …

the natural history of postoperative C rohn's disease recurrence

A Buisson, JB Chevaux, PB Allen… - Alimentary …, 2012 - Wiley Online Library
Background Surgical resection of the diseased bowel in C rohn's disease is unfortunately
not curative, and postoperative recurrence remains a problem in these patients. Aim To …

Infliximab prevents Crohn's disease recurrence after ileal resection

M Regueiro, W Schraut, L Baidoo, KE Kip… - Gastroenterology, 2009 - Elsevier
BACKGROUND & AIMS: Crohn's disease commonly recurs after intestinal resection. We
evaluated whether the administration of infliximab after resective intestinal surgery for …

Aminosalicylates for induction of remission or response in Crohn's disease

WC Lim, Y Wang, JK MacDonald… - Cochrane Database of …, 2016 - cochranelibrary.com
Background Randomized trials investigating the efficacy of aminosalicylates for the
treatment of mildly to moderately active Crohn's disease have yielded conflicting results. A …

Effect of resection margins on the recurrence of Crohn's disease in the small bowel: a randomized controlled trial

VW Fazio, F Marchetti, JM Church, JR Goldblum… - Annals of …, 1996 - journals.lww.com
Objective The authors assess the effect of surgical margin width on recurrence rates after
intestinal resection for Crohn's Disease (CD). Background The optimal width of margins …

European evidence based consensus on the diagnosis and management of Crohn's disease: special situations

R Caprilli, MA Gassull, JC Escher, G Moser… - Gut, 2006 - gut.bmj.com
This third section of the European Crohn's and Colitis Organisation (ECCO) Consensus on
the management of Crohn's disease concerns postoperative recurrence, fistulating disease …

Drug-induced pancreatitis: an update

CD Trivedi, CS Pitchumoni - Journal of clinical gastroenterology, 2005 - journals.lww.com
Methods: We searched the National Library of Medicine/Pubmed for reported cases of DIP
from 1966 to April 30, 2004. Medications implicated in AP are classified based on the …

IOIBD technical review on endoscopic indices for Crohn's disease clinical trials

L Vuitton, P Marteau, WJ Sandborn, BG Levesque… - Gut, 2016 - gut.bmj.com
Background Crohn's disease (CD) is a chronic disabling and progressive IBD. Only
strategies looking beyond symptoms and based on tight monitoring of objective signs of …